Extremely lately, preliminary outcomes from a 3rd trial comparing ibrutinib vs . observation have been presented.a hundred and five Sufferers acquiring ibrutinib had an extended function-free survival, but no General survival gain, although the effects had been however immature. Furthermore, While i